• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study on the pathogenetic roles of pancretic antigen on the beta-cell destruction in insulin-dependent diabetes mellitus

Research Project

Project/Area Number 09671085
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内分泌・代謝学
Research InstitutionOkinaka Memorial Institute for Medical Research

Principal Investigator

KOBAYASHI Tetsuro  Okinaka Memorial Institute for Medical Research, 研究員 (30113442)

Co-Investigator(Kenkyū-buntansha) NAKANISHI Koji  Okinaka Memorial Institute for Medical Research, 研究員 (80211423)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 1998: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1997: ¥2,800,000 (Direct Cost: ¥2,800,000)
KeywordsIDDM / GAD antibodies / ICA / epitope / slowly progressive IDDM / Soluble HLA / インスリン依存型糖尿病 / Slowly progressive IDDM / CAD抗体
Research Abstract

In order to study a pathogenetic roles of pancreatic antigen on beta-cell failure in insulin-dependent diabetes mellitus (IDDM), characterization of autoantibodies to glutamic acid decarboxylase 65 (GAD65), a representative autoantigen in LDDM, was performed.We created chimeric GAD65 and GAD67 protein molecules to examine the epitopes of autoantibodies to GAD65 (GAD65Ab) to different regions of GAD65 molecules.Longitudical changes of the reactivity of GAD65Ab in acute-onset IDDM and slowly progressive IDDM were also studies.
The constructed molecules includes ; the chimera GAD65(1-244)/GAD67(253-369)/GAD65(360-585) : [A], the chimera GAD65(1-359)/GAD67(370-451)/GAD65(443-585) : [B], chimera GAD65(1-244)/GAD67(253-594) : [C], chimera GAD65(1-244)/GAD67(253-451)/GAD65(443-585) : [D], the chimera GAD65(1-442)/GAD67(452-594) : [E], GAD67(1-443)/GAD65(451-585) : [H], chimera GAD65(1-83)/ GAD67(89-594) : [N].
Sera from the patients with acute-onset IDDM reacted with chimera [B] and [E].However the reactivities with chimera [A] [D], [N] and [H] were reduced significantly, showing the epitope of GAD65Ab reside on amino acid (AA) residues 244-360 and 244-443.Sera from the patients with slowly progressive IDDM reacted with chimera [N], [A], [B], [D], [E] and [H], these reactivity was reduced when incubated with chimera [C].These results shows that GADAb epitope in slowly progressive IDDM resides AA residues 244-585 and 1-83.
The reactivity of sera from both acute-onset IDDM and slowly progressive IDDM to chimera GAD molecules did not change 0.5 and 5 years after the onset of diabetes.These results suggest that "epitope spreading" of GAD65 did not occure in both type of IDDM.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] Yoshihiko Suzuki: "Islet cell antibody in mitochondrial diabetes." Diabetes Res.Clin Pract. 35. 163-165 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshihiko Suzuki: "Diabetes Mellitus associated with the 3243 mitochondrial tRNA ^<leu(UUR)> mutation:Insulin secretion and sensitivity." Metabolism. 46. 1019-1023 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Koji Nakanishi: "Synchronous decline of serum-soluble HLA class I antigen and β-cell function in insulin-dependent diabetes mellitus." Clin Immun and Immunopathol. 85. 246-252 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yasushi Inoue: "Recovery of Pancreatic β-cell function in hemochromatosis:combined tretment with recombinant Human Erythropoietin and phlebotomy" Am J Med Scienc. 314. 401-402 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tetsuro Kobayashi: "In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3234." Diabetes. 46. 1567-1571 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tetsuro Kobayashi: "Mutation at nucleotide position 3243 of the mitochondrial DNA as a cause of IDDM-a meta-analysis-response." Diabetologia.40. 1495-1496 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 小林哲郎: "GAD抗体とその臨床的意義。" 総合臨床2. 46. 377-378 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 小林哲郎: "Slowly progressive IDDM (SPIDDM)." 別冊・医学のあゆみ内分泌、代謝疾患-State arts.475-477 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshitomo Suznki et al.: "Islet cell antibody in mitochondrial diabetes." Diabetes Res. Clin Pract. 35. 163-165 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshitomo Suzuki et al.: "Diabetes Mellitus associated with the 3243 mitochondrial tRNA^<leu(UUR)> mutation : Insulin secretion and sensitivity." Metabolism. 46. 1019-1023 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Koji Nakanishi et al.: "Synchronous decline of serum-soluble HLA class I antigen and beta-cell function in insulin-dependent diabetes mellitus." Clin Immun and Immunopathol. 85. 246-252 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yasushi Inoue et al.: "Recovery of Pancreatic beta-cell function in hemochromatosis : combined treatment with recombinant Human Erythropoietin and phlebotomy." Am J Med Scienc. 314. 401-402 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tetsuro Koabayshi et al.: "In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3234." Diabetes. 46. 1567-1571 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tetsuro Koabayashi et al.: "Mutation at nucleotide position 3243 of the mitochondrial DNA as a cause of IDDM-a meta-analysis-response." Diabetologia. 40. 1495-1496 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tetsuro Kobayashi et al.: "Slowly progressive IDDM" Diabetes in the New Millennium. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Tetsuro Kobayashi: "Slowly progressive IDDM." Diabetes in the Millennium. in press.

    • Related Report
      1998 Annual Research Report
  • [Publications] Koji Nakanishi: "Synchronous decline of serum-soluble HLA class I antigen and β-cell function in insulin-dependent diabetes mellitus." Cline Immun and Immunopathol. 85. 246-2252 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tetsuro Kobayashi: "In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243." Diabetes. 46. 1567-1571 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Tetsuro Kobayashi: "Mutation at nucleotide position 3243 of the mitochondrial DNA as a cause of IDDM-a meta-analysis-response." Diabetologia. 40. 1495-1496 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi